February 26, 2024 News by Andrea Lobo, PhD High incidence, prevalence of pediatric-onset MS in Sweden Sweden has a consistently high incidence and prevalence of pediatric-onset multiple sclerosis (PoMS), according to a recently published study. Incidence measures the number of new cases identified during a certain period, while prevalence measures the proportion of people in the population with the condition. Data show the disease is…
April 6, 2021 News by Forest Ray PhD Rates of MS Seem to Rise With Nations’ Prosperity Rates of multiple sclerosis (MS) appear to rise with measures of prosperity, occurring more frequently in developed countries, according to a recent study. The reasons for such disparities may be linked to better access to diagnostic facilities in developed countries, as well as increased exposure to factors, such as…
August 6, 2020 News by InĆŖs Martins, PhD MS Patients Show Greater Risk of Infections Before and After Diagnosis, Study Finds Multiple sclerosis (MS) patients have a greater risk of infections, particularly urinary and kidney infections, around the time of their diagnosis, compared with individuals without MS, a large Swedish population-based study found. Rates of serious and non-serious infections, as well as infections caused by bacteria, virus, and fungus, also…
June 18, 2020 News by Joana Carvalho, PhD Depression 2 to 3 Times More Likely in MS Patients Than Others, Study Finds A likelihood of depression is two to three times higher inĀ multiple sclerosis (MS) patients in the U.S. and U.K. than in similar groups of people in these countries without the disease, a study reported. This risk was also “most evident in the first five yearsĀ after MS diagnosis” among…
February 17, 2020 News by Marisa Wexler, MS Number of People with MS in UK More Than Previously Estimated New data from Public Health England (PHE) and the U.K. MS Society show that the number of people with multiple sclerosis (MS) in the United Kingdom is now more than 130,000 ā about one in every 500 people living in the country. This is an increase of…
June 17, 2019 News by Alberto Molano, PhD Relative Cancer Risk is Higher in MS Patients Who Switch Disease-modifying Treatments More Frequently, Study Finds The relative risk of developing cancer was found to be higher in multiple sclerosis (MS) patients who more frequently switched between disease-modifying treatments, according to a study. In addition, researchers found an increased incidence of cancer in male MS patients from 20 to 50 years old, and in female…
November 20, 2017 News by Larry Luxner Nearly 1 Million Americans Have Multiple Sclerosis, NMSS Prevalence Study Finds An estimated 947,000 people in the U.S. have multiple sclerosis (MS) ā more than double the long-accepted figure of 400,000 ā according to a newly completed study organized and funded by the National Multiple Sclerosis Society (NMSS). āThis is definitely not what we expected,ā Ā Nicholas G. LaRocca, vice…
October 28, 2015 News by Patricia Silva, PhD Multiple Sclerosis Therapeutics’ Market Value to Reach $20B by 2024 RnR Market Research, a company offering market research reports on fields that include healthcare, pharmaceutical, technology, energy, and industry, recently publicized a new report on the epidemiology of multiple sclerosis (MS) and a forecast of its therapeutic market value. The report is entitled āEpiCast Report: Multiple Sclerosis – Epidemiology…